Autolus Therapeutics plc – Filings and Transcripts

NASDAQ: AUTL
Share price (7/2/26): $1.58
Market cap (7/2/26): $421 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Delaying amendment

Delaying amendment

Shelf registration

Shelf registration

Prospectus supplement

Ownership Filter

Young William D

Rao Madduri Ravin

Richardson Ryan

Leiderman Elisabeth

News Filter

Shareholder Vote Results

Registered Number 11185179 (England & Wales) Annual Report and Financial Statements for the Year Ended 31 December 2025 for Autolus Therapeutics Plc

Investor Presentation

Announces Initiative to Support Operational Efficiency and Cost Reduction

Change in Certifying Accountant, Financial Statements or Exhibits

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC